宁波迦南智能电气股份有限公司 关于对外投资设立控股子公司的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、本次对外投资事项概述 为进一步推进公司战略布局，促进经营发展，扩大公司海外市场规模，宁波 迦南智能电气股份有限公司（以下简称"公司"或"迦南智能"）与付卓女士、 卢培信先生于 2025 年 6 月 12 日签署了《三方合资协议》（以下简称"合资协议"）， 根据合资协议，公司与付卓女士、卢培信先生拟在浙江省杭州市共同出资设立浙 江迦能国际电力有限公司（原暂定名称为：浙江迦能国际发展有限公司，以下简 称"迦能国际"），迦能国际注册资本为人民币 1,000 万元，其中公司以自有资金 出资合计 510 万元，占合资公司注册资本的 51.00%，付卓女士以货币出资 250 万 元，占合资公司注册资本的 25.00%，卢培信先生以货币出资 240 万元，占合资公 司注册资本的 24.00%。合资公司设立后将纳入公司合并报表范围，成为公司的控 股子公司。具体内容详见公司于 2025 年 6 月 13 日披露于巨潮资讯网的《关于对 外投资设立控股子公司的公告 ...

Core Viewpoint - Canaan Intelligent (300880) announced the establishment of a joint venture, Zhejiang Jianeng International Development Co., Ltd., in Hangzhou, Zhejiang Province, with partners Fu Zhuo and Lu Peixin [1] Group 1 - Canaan Intelligent will invest 5.1 million yuan, holding a 51% stake in the joint venture [1] - Fu Zhuo will contribute 2.5 million yuan for a 25% stake [1] - Lu Peixin will invest 2.4 million yuan, holding a 24% stake [1] Group 2 - The joint venture will be included in Canaan Intelligent's consolidated financial statements, becoming a subsidiary of the company [1]

证券代码：300880 证券简称：迦南智能 公告编号：2025-026 宁波迦南智能电气股份有限公司 本次交易不构成关联交易，不构成《上市公司重大资产重组管理办法》规定 的重大资产重组，无需经过有关部门批准。 二、交易对手的基本情况 （一）合资方付卓女士基本情况 1、姓名：付卓 关于对外投资设立控股子公司的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、本次对外投资事项概述 1、对外投资的基本情况 为进一步推进公司战略布局，促进经营发展，扩大公司海外市场规模，宁波 迦南智能电气股份有限公司（以下简称"公司"或"迦南智能"）与付卓女士、 卢培信先生于 2025 年 6 月 12 日签署了《三方合资协议》（以下简称"合资协议"）， 根据合资协议，公司与付卓女士、卢培信先生拟在浙江省杭州市共同出资设立浙 江迦能国际发展有限公司（暂定名，具体以登记机关核准为准。以下简称"合资 公司"），合资公司注册资本为人民币 1,000 万元，其中公司以自有资金出资合计 510 万元，占合资公司注册资本的 51.00%，付卓女士以货币出资 250 万元，占合 资公司注册资 ...

Group 1 - The A-share virtual power plant sector showed significant activity at the beginning of trading, with New Alliance Electronics, China Electric Power Xinlong, and Jinzhih Technology all hitting the daily limit up [1] - Hengshi Technology experienced a substantial increase of 15%, while Wansheng Intelligent and Kanan Intelligent also saw gains [1]

证券代码：300880 证券简称：迦南智能 公告编号：2025-025 宁波迦南智能电气股份有限公司 关于重大经营合同中标的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、中标项目的主要内容 宁波迦南智能电气股份有限公司（以下简称"本公司"或"公司"）于 2025 年 6 月 4 日收到国家电网有限公司及国网物资有限公司发给本公司的中标通知 书，在"国家电网有限公司 2025 年第三十一批采购（营销项目第一次计量设备 招标采购）"（招标编号：0711-25OTL04222007）项目中，公司为此项目 A 级 单相智能电能表、B 级三相智能电能表、C 级三相智能电能表、专变采集终端的 中标人，合计中标金额约为 14,904.35 万元。上述中标项目相关合同在收到中标 通知书之日起 30 天内签署，履行期限以最终签署的合同为准。 公司已于 2025 年 5 月 28 日在中国证监会指定的创业板信息披露网站巨潮资 讯网（http://www.cninfo.com.cn）披露了《关于重大经营合同预中标的提示性公 告》（公告编号：2025-022）。 法定代表 ...

证券代码：300880 证券简称：迦南智能 公告编号：2025-023 宁波迦南智能电气股份有限公司 2024 年年度权益分派实施公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 宁波迦南智能电气股份有限公司（以下简称"本公司"或"公司"）2024 年年度利润分配方案（以下简称"权益分派方案"）已获 2025 年 5 月 23 日召开 的 2024 年年度股东大会审议通过，现将权益分派事宜公告如下： 1、公司 2024 年年度权益分派方案已获 2025 年 5 月 23 日召开的 2024 年年 度股东大会审议通过，具体方案为：以截至目前的总股本 195,137,280 股为基数， 向全体股东每 10 股派发现金红利人民币 4.5 元（含税），不转增、不送股，合 计派发现金红利人民币 87,811,776.00 元，本次现金分红金额占利润分配总额的 100%。 在权益分派方案披露日至实施权益分派股权登记日期间，公司股本如发生变 动，将按照分配总额不变的原则对分配比例进行调整。 2、本次权益分派方案披露至实施期间，公司总股本未发生变化。 3、本次实施的权益分 ...

证券代码：300880 证券简称：迦南智能 公告编号：2025-024 宁波迦南智能电气股份有限公司 关于完成工商变更登记并换发营业执照的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 宁波迦南智能电气股份有限公司（以下简称"公司"）于 2025 年 4 月 21 日召开第三届董事会第十七次会议，审议通过了《关于变更公司注册资本及修订 <公司章程>并办理工商变更登记的议案》，并于 2025 年 5 月 23 日经 2024 年年 度股东大会审议通过，具体内容详见公司于 2025 年 4 月 23 日、2025 年 5 月 23 日在巨潮资讯网（www.cninfo.com.cn）披露的相关公告。 2025 年 6 月 4 日，公司完成了上述事项的工商变更登记手续及《宁波迦南 智能电气股份有限公司章程》备案手续，取得了宁波市市场监督管理局换发的《营 业执照》。变更后的企业登记信息如下： 一、《营业执照》的基本信息 1、统一社会信用代码：913302827133274413 5、法定代表人：章恩友 6、注册资本：壹亿玖仟伍佰壹拾叁万柒仟贰佰捌拾元 7、成立日 ...

证券代码：300880 证券简称：迦南智能 公告编号：2025-022 宁波迦南智能电气股份有限公司 关于重大经营合同预中标的提示性公告 国家电网有限公司于 2025 年 5 月 27 日在国家电网有限公司电子商务平台 （https://ecp.sgcc.com.cn/ecp2.0/portal/）公告了"国家电网有限公司 2025 年第三 十一批采购（营销项目第一次计量设备招标采购）推荐的中标候选人公示（招标 编号：0711-25OTL04222007）"，宁波迦南智能电气股份有限公司（以下简称 "公司"）为评标委员会推荐的中标候选人，公示期 3 日。现将相关预中标情况 提示如下： 确定。本次中标预计对公司未来经营业绩有积极影响，其合同的履行不影响公司 经营的独立性。 三、预中标项目风险提示 一、预中标项目的主要内容 公司本次预中标项目为国家电网有限公司 2025 年第三十一批采购（营销项 目第一次计量设备招标采购）项目，该项目由国家电网有限公司委托国网物资有 限公司作为招标代理机构采用公开招标方式进行。 根据公示内容，公司本次预中标共 6 个标包，预中标产品包括：A 级单相智 能电能表、B 级三相智能电能 ...

Group 1: Company Leadership Changes - Longi Green Energy announced that Li Zhenguo will resign from the positions of General Manager and Legal Representative to focus on R&D and technology management, while continuing as the head of the Central Research Institute and Chief Technology Officer [2] - The company appointed Zhong Baoshan as the new General Manager, and this leadership change is not expected to impact the company's operations [2] Group 2: Contracts and Agreements - Pingzhi Information signed an AI computing power technology service framework agreement with China Telecom's Shaanxi branch, with a total contract value of approximately 246 million yuan [3] - The actual execution amount will depend on specific orders, and the agreement is not expected to have a significant impact on the company's annual performance [3] Group 3: Share Issuance and Stock Transactions - *ST Songfa announced the issuance of 738 million new shares at a price of 10.16 yuan per share for asset acquisition [5] - Shenghong Technology set the preliminary inquiry transfer price at 65.85 yuan per share, with 24 institutional investors participating in the inquiry [3] Group 4: Shareholder Actions - Xinhua Medical's controlling shareholder plans to increase holdings by 100 million to 200 million yuan [6] - Several companies, including Yongmaotai and Green Harmony, announced plans for share reductions by up to 3% of total shares [6] Group 5: Corporate Developments - Rongsheng Environmental Protection reported that its controlling shareholder, Feng Ronghua, has been taken into custody by law enforcement, but this matter is unrelated to the company [4] - Chongqing Steel terminated the absorption merger with its wholly-owned subsidiary [7]

Group 1 - Company Sun Energy plans to repurchase shares worth between 100 million to 200 million yuan for cancellation, with a maximum repurchase price of 6.69 yuan per share [1] - Company Runyang Technology intends to invest up to 300 million yuan in Shanghai Fourier Intelligent Technology Co., with a pre-investment valuation of 8 billion yuan [1] - Company Heng Rui Medicine's subsidiary has received approval for clinical trials of SHR-4712 injection for treating advanced solid tumors [2] Group 2 - Company Lianhuan Pharmaceutical plans to increase capital by 60 million yuan for its wholly-owned subsidiary [2] - Company Hongchang Electronics' subsidiary plans to increase capital by 10 million USD for its other subsidiary [2] - Company Sichuan Meifeng intends to repurchase shares worth between 50 million to 70 million yuan for cancellation, with a maximum repurchase price of 10.07 yuan per share [2] Group 3 - Company Lian Micro plans to liquidate and deregister Jiaxing Kangjing Semiconductor Industry Investment Partnership [4] - Company Jiutian Pharmaceutical has received approval for clinical trials of PDX-04 drug for treating acute gout attacks [5] - Company Pingzhi Information has signed a framework agreement with China Telecom for a GPU computing power project worth approximately 246 million yuan [7] Group 4 - Company Jiu Zhi Tang's subsidiary has initiated Phase II clinical trials for new drug YB211 aimed at treating acute bacterial skin infections [8] - Company Fosun Pharma's subsidiary has received orphan drug designation for HLX22 for gastric cancer treatment in the EU [9] - Company Jianyou Co. plans to repurchase shares worth between 20 million to 40 million yuan for employee stock ownership plans [11] Group 5 - Company Zhi Zheng Co. announced the resignation of its vice president due to personal reasons [13] - Company He Mai Co. signed a cooperation agreement for household photovoltaic systems worth 1 billion yuan [14] - Company Jinan Intelligent's subsidiary won a project bid for electric vehicle charging stations, expected to positively impact performance [16] Group 6 - Company Gaotie Electric plans to distribute a cash dividend of 0.012 yuan per share [18] - Company Guyue Longshan plans to distribute a cash dividend of 0.08 yuan per share [18] - Company Yongmaotai's shareholders plan to reduce their holdings by up to 2.66% of the company's shares [19] Group 7 - Company Tian Cheng Technology's subsidiary received a land idle fee notice for 2.1658 million yuan due to project delays [20] - Company Guangri Co. appointed a new vice president and board secretary to enhance governance [21] - Company Design General Institute won multiple major projects totaling approximately 390 million yuan [22] Group 8 - Company Fuxie Environmental signed a significant contract worth 244 million yuan for a sewage treatment project [23] - Company Lujiazui announced the resignation of its vice chairman due to job transfer [24] - Company Three Squirrels' H-share issuance application has been accepted by the CSRC [24] Group 9 - Company Kanghong Pharmaceutical's subsidiary received approval for clinical trials of KH617 for glioblastoma treatment [25] - Company Xin Zhu Co. announced a suspension of trading to plan an asset acquisition from its controlling shareholder [26] - Company Jianxin Co. announced plans for share reductions by several directors and senior management [28]